Boniva and Ovarian disorder - a phase IV clinical study of FDA data

Summary:

Ovarian disorder is reported as a side effect among people who take Boniva (ibandronate sodium), especially for people who are 60+ old, have been taking the drug for 2 - 5 years also take Fosamax, and have Crohn's disease.

The phase IV clinical study analyzes which people have Ovarian disorder when taking Boniva. It is created by eHealthMe based on reports of 26,949 people who have side effects when taking Boniva from the FDA, and is updated regularly.

What is Boniva?

Boniva has active ingredients of ibandronate sodium. It is often used in osteoporosis. eHealthMe is studying from 27,340 Boniva users. Check the latest studies of Boniva.

What is Ovarian disorder?

Ovarian disorder (disease of ovary) is found to be associated with 183 drugs and 271 conditions by eHealthMe. Check the latest studies of Ovarian disorder.

On Aug, 11, 2026

26,949 people reported to have side effects when taking Boniva.
Among them, 24 people (0.09%) have Ovarian disorder.

Among these 24 people:

How long have people been on Boniva when they have Ovarian disorder? *

What is the age of people who have Ovarian disorder when taking Boniva? *

What are other drugs people take besides Boniva? *

What are other side effects people have besides Ovarian disorder? *

High Blood Pressure: 19 people, 79.17%
Femur Fracture: 18 people, 75.00%
Fall: 16 people, 66.67%
Low Turnover Osteopathy (slow removal of old bone and its replacement by new bone): 16 people, 66.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 12 people, 50.00%
Adverse Event: 11 people, 45.83%
Rickets (softening of bones): 11 people, 45.83%
Small Intestinal Obstruction (blockage in small intestine): 10 people, 41.67%
Fibrocystic Breast Disease (a condition causing breast pain, cysts, and noncancerous breast lumps, affects many women): 10 people, 41.67%
Joint Pain: 10 people, 41.67%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 16.67%
Resorption Bone Increased: 1 person, 4.17%
Neoplasm Recurrence (reoccurrence of tumour): 1 person, 4.17%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 1 person, 4.17%
Bone Density Decreased: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Boniva and have Ovarian disorder?

- Check whether Ovarian disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Boniva:

Boniva (27,340 reports)

Browse all side effects of Boniva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ovarian disorder:

Ovarian disorder (183 drugs)

Browse all the conditions that are associated with Ovarian disorder:

Ovarian disorder (271 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ibandronate sodium (the active ingredients of Boniva) and Boniva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.